Dual‐Targeted M1 Macrophage Extracellular Vesicles Reprogram the Tumor Microenvironment and Enhance Natural Killer Cell Immunotherapy in Breast Cancer
Su Jin Kang, Gichan Baek, Suwun Ju, Gunhee Kim, Seongjin Gwak, Won Jong Rhee · 2026
Read Dual‐Targeted M1 Macrophage Extracellular Vesicles Reprogram the Tumor Microenvironment and Enhance Natural Killer Cell Immunotherapy in Breast Cancer by Su Jin Kang, Gichan Baek, Suwun Ju, Gunhee Kim, Seongjin Gwak, Won Jong Rhee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13626480.txt.
Description
Su Jin Kang and co-authors turn the fat droplets shed by fighter immune cells into bridges between killer cells and breast tumors. Natural killer cells often fail against solid tumors because the tumor neighborhood suppresses them and contact is fleeting. The team's vesicles come from M1 macrophages, the inflammatory kind, and carry two grips. Hyaluronic acid latches a marker on killer cells. A ring peptide grabs tumor integrins. One particle thus holds both sides at once.
In dish and animal studies the bridged killer cells clustered at tumors, woke up, and killed far more cancer cells. The vesicles also spilled inflammatory signals that flipped the tumor neighborhood from suppressive to hostile. Dual gripping plus reprogramming, the authors argue, answers two reasons cell therapy fails at once.
Catalog record
| CREATOR | Su Jin Kang, Gichan Baek, Suwun Ju, Gunhee Kim, Seongjin Gwak, Won Jong Rhee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |